MiNK Therapeutics (INKT) Misses Q4 EPS by 56c

MiNK Therapeutics (NASDAQ: INKT) reported Q4 EPS of ($0.56).

For earnings history and earnings-related data on MiNK Therapeutics (INKT) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg